Verified employee & interview reviews

Alembic Pharmaceuticals Reviews

Vadodara, Gujarat

5.0/ 5

2 reviews

Alembic Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Vadodara, Gujarat. Established in 1907, it stands as one of India's oldest and most respected vertically integrated pharmaceutical enterprises. The company operates across the entire pharmaceutical value chain, including research and development, manufacturing, and the marketing of finished dosage formulations, active pharmaceutical ingredients, and intermediates. Over its century-long legacy, Alembic has expanded its operational footprint to supply high-quality and affordable generic and branded medicines to healthcare providers and patients in more than 90 countries worldwide, with a strong emphasis on regulated markets such as the United States and Europe. The core operations of Alembic Pharmaceuticals are divided into three primary business segments: India Formulations, International Generics, and Active Pharmaceutical Ingredients (APIs). In the domestic market, the company is a prominent player addressing various therapeutic areas, including cardiology, dermatology, oncology, ophthalmology, gastroenterology, metabolic disorders, orthopedics, gynecology, nephrology, urology, and anti-infectives, alongside treatments for cold and cough. Notably, Alembic is a market leader in the macrolides segment of anti-infective drugs in India. The company also operates an Animal Health Division established in 1986, which develops specialized pharmaceutical products and feed additives for livestock, poultry, and companion animals. Alembic maintains a robust manufacturing and research infrastructure to support its global supply chain. It operates multiple state-of-the-art manufacturing facilities across India, including locations in Panelav and Karakhadi in Gujarat, Sikkim, Pithampur, and Baddi in Himachal Pradesh. These facilities are compliant with current Good Manufacturing Practices (cGMP) and have received approvals from major international regulatory bodies, including the United States Food and Drug Administration (USFDA). The Panelav facility houses both API and formulation plants, while the Vadodara site possesses the largest fermentation capacity in India. To drive innovation, the company manages dedicated research and development centers in India and the United States, focusing on complex generics, biosimilars, and differentiated formulations. Financially, Alembic Pharmaceuticals is a publicly traded entity listed on both the National Stock Exchange of India (NSE) and the Bombay Stock Exchange (BSE) under the ticker symbol APLLTD. For the fiscal year ending March 31, 2025, the company reported a consolidated revenue from operations of approximately INR 6,672 crore and a net income of INR 583.42 crore. The company employs over 16,000 people globally. The leadership team is headed by Executive Chairman Chirayu Amin, alongside Managing Directors Pranav Amin and Shaunak Amin, who continue to advance the company's innovation-led growth strategy. Through strategic initiatives, such as the acquisition of Aleor Dermaceuticals and US-based Utility Therapeutics, Alembic continues to strengthen its specialized product pipeline.